Evaluasi Penggunaan Antibiotik pada Pasien Pneumonia Komunitas Menggunakan Metode Gyssens

Dwi Aulia Zahra; Rezlie Bellatasie; Putri  Ramadhani; Widya  Kardela; Wulan Panduwi Melasari; Hendri Satria Kamal Uyun

doi:10.15408/pbsj.v8i1.51659

Authors

Dwi Aulia Zahra Program Studi S1 Farmasi, Sekolah Tinggi Ilmu Farmasi Padang, Jl. Kurao Pagang, Padang, Indonesia, 25147
Rezlie Bellatasie Sekolah Tinggi Ilmu Farmasi Padang, Jl. Kurao Pagang, Padang, Indonesia, 25147 https://orcid.org/0000-0002-4557-779X
Putri Ramadhani Sekolah Tinggi Ilmu Farmasi Padang, Jl. Kurao Pagang, Padang, Indonesia, 25147
Widya Kardela Sekolah Tinggi Ilmu Farmasi Padang, Jl. Kurao Pagang, Padang, Indonesia, 25147
Wulan Panduwi Melasari Fakultas Farmasi, Universitas Sumatera Utara, Jl. Tri Dharma No. 5, Medan, Indonesia, 20222
Hendri Satria Kamal Uyun Sekolah Tinggi Ilmu Farmasi Padang, Jl. Kurao Pagang, Padang, Indonesia, 25147

DOI:

https://doi.org/10.15408/pbsj.v8i1.51659

Abstract

Pneumonia is an infection of the lower respiratory tract that remains a significant cause of morbidity and mortality globally, including in Indonesia. Irrational antibiotic use among pneumonia patients can promote the development of antibiotic resistance, elevate treatment expenses, and adversely affect clinical outcomes. This study aims to evaluate the rationality of antibiotic use among patients with community-acquired pneumonia in the internal medicine inpatient ward of a government hospital in Padang City, West Sumatra, using the Gyssens method. This study employed a descriptive, observational, cross-sectional design from January to March 2025. A total of 29 patients were selected based on the inclusion criteria. The most commonly prescribed antibiotics were third-generation cephalosporins (especially ceftriaxone and cefixime), macrolides (azithromycin), and fluoroquinolones (levofloxacin). The results showed that 18 patients (62.07%) used antibiotics rationally (category 0), while 11 patients (37.93%) used antibiotics irrationally in categories IIIa (17.24%), IIa (17.24%), and I (3.45%). There still needs to be better monitoring of antibiotic use by healthcare workers to improve the accuracy of antibiotic choices for patients.

References

Aditiatama, Y. et al. (2025). Evaluasi Kualitatif dan Kuantitatif Penggunaan Antibiotik pada Pasien Pneumonia Rawat Inap di RSPAD Gatot Soebroto Periode Januari 2021-Desember 2022. J.Sains.Kes, 6, (1), pp. 9-22

Anggita, D. et al. (2022). Mekanisme Kerja Antibiotik. UMI Medical Journal, 7 (1), pp. 46-58

Apriliany, F., Olivia U. R., & Fitriya E.V. (2022). Rasionalitas Antibiotik Empiris pada Pasien Hospital Acquired Pneumonia (HAP) di RSUD Provinsi NTB. Majalah Farmasi Dan Farmakologi, 26, (1), pp. 26-31.

Assefa, M. (2022) ‘Multi‑drug resistant gram‑negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns’, Pneumonia, 14, (4), pp.1-12

Bellatasie, R. et al. (2023). Evaluation of Antibiotic Prescription in Community-Acquired Pneumonia Patients with Gyssens Method. IJPRA, 8, (4), pp. 2057-2062

Candel, F. J. et al. (2023). Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review. Journal of Clinical Medicine, 12, (6864), pp. 1-34

Dharmawan, A., & Layanto, N. (2022). Efektivitas Ceftazidime-Avibactam terhadap Bakteri Gram Negatif Penghasil Enzim Karbapenemase. Jurnal MedScientiae, 1(1), pp. 40-46.

Goncalves-Pereira, J. et al. (2025). Community-acquired pneumonia mortality trends according to age and gender: 2009 to 2019. BMC Pulmonary Medicine, 25, (391), pp. 1-10

Hardiana, I. et al. (2021). Evaluasi Penggunaan Antibiotika Pada Pasien Pneumonia Komunitas Di Instalasi Rawat Inap Rspad Gatot Subroto. MFF, 25, (1), pp. 1-6

Indriani, L., & Zunnita, O. (2018). Penilaian Terhadap Rasionalitas Penggunaan Antibiotika Pada Balita Penderita Pneumonia Puskesmas Bogor Utara. Fitofarmaka: Jurnal Ilmiah Farmasi, 8, (2), pp. 92-98.

Kautsar, M., (2020). Analisis Faktor-Faktor Yang Berhubungan Dengan Lama Rawat Inap Pasien Pneumonia Di RSU Cut Meutia Aceh Utara Tahun 2022. Skripsi. Lhokseumawe: Universitas Malikussaleh.

Kementerian Kesehatan Republik Indonesia (2023). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Pneumonia. Available at: PNPK 2023 - Tata Laksana Pneumonia Pada Dewasa

Kementerian Kesehatan Republik Indonesia (2019). Laporan Nasional Riskesdas 2018. Jakarta: Lembaga Penelitian dan Pengembangan Kesehatan

Kurniawan, Y. S., Priyangga, K. T. A., Krisbiantoro, P. A., & Imawan, A. C. (2022). Analisis Spasial Kasus Pneumonia di Provinsi Sumatera Barat (Daratan) Tahun 2022. Journal of Multidiciplinary Applied Natural Science, 1(1), pp. 1–12.

Lemmetyinen, R. E., Salmi, S, K, T., But, A., Renkonen, R., Pekkanen, J., Haukka, J., & Karjalainen, J. (2023). Comorbidities associated with adult asthma: a population- based matched cohort study in Finland. BMJ Open Respiratory Research, pp. 11, 1-9.

Magfirah, N. (2022). Evaluasi Rasionalitas Penggunaan Antibiotik Pada Pasien Pneumonia di RSUD Majene. Skripsi. Makassar: Universitas Islam Negeri Alauddin

Nuraini, N., & Yulianti, N. (2020). Profil Pasien PPOK dengan Komplikasi Pneumonia di RSUD Arifin Achmad Pekanbaru. Jurnal Online Mahasiswa (JOM). Fakultas Kedokteran Universitas Riau, 7(1), pp. 1–7.

Parisa, N., Parulian, T., & Adelia, R, A, A., (2021). Rasionalitas Penggunaan Azitromisin pada Pasien ISPA di Rumah Sakit Moh. Hoesin (RSMH) Palembang. Jurnal Mandala Pharmacon Indonesia, 8(1), pp. 34-48.

Perhimpunan Dokter Paru Indonesia (PDPI). (2022). Pedoman Diagnosis dan Penatalaksanaan Pneumonia Komunitas di Indonesia. Jakarta: Perhimpunan Dokter Paru Indonesia.

Saraswati, S, I., Bagiada, I, M., Suardamana, K., & Kurniari, P, K. (2019). Profil Pasien Dengan Pneumonia Komunitas Yang Dirawat Di Rsud Wangaya Denpasar Pada Bulan Oktober 2019 – Desember 2019. Jurnal Medika Udayana, 11, (1), pp. 18-24.

Surbakti, R, M, M, B ., Sahputri, J., & Yuziani. (2023). Rasionalitas Penggunaan Antibiotik Terhadap Pengobatan Pneumonia Rumah Sakit X Utara Tahun 2023. Jurnal Ilmiah Manusia Dan Kesehatan, 8(2), pp. 389-399.

WHO (2024). The top 10 causes of death. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

Zasowski, Evan J. & Blackford, Martha G (2023). Lower Respiratory Tract Infections in DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 12th ed. New York: McGraw-Hill, pp. 1791-1812